Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA BIOLOGICAL BUFFERS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 NORTH AMERICA BIOLOGICAL BUFFER MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE U.S.
5.2 REGULATORY SUBMISSIONS
5.3 INTERNATIONAL HARMONIZATION
5.4 EUROPE REGULATORY SCENARIO
5.5 REGULATORY SUBMISSIONS
5.6 INTERNATIONAL HARMONIZATION
5.7 JAPAN REGULATORY SCENARIO
5.8 REGULATORY SUBMISSIONS
5.9 INTERNATIONAL HARMONIZATION
5.1 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES
6.1.2 INCREASED ADOPTION OF WESTERN BLOT AND ELISA TECHNIQUES
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN ASSAY DEVELOPMENT
6.1.4 ADVANCEMENTS IN PROTEOMICS AND GENOMICS
6.2 RESTRAINTS
6.2.1 LIMITED SHELF LIFE OF BLOCKING BUFFERS
6.2.2 POTENTIAL OF CONTAMINATION OR BATCH INCONSISTENCIES FOR BIOLOGICAL BUFFERS
6.3 OPPORTUNITY
6.3.1 INCREASE IN PUBLIC-PRIVATE FUNDING IN BIOMEDICAL RESEARCH
6.3.2 ANALYTICAL METHODS FOR FOOD SAFETY AND ENVIRONMENTAL TESTING.
6.3.3 DIAGNOSTIC AND CLINICAL APPLICATIONS USE BLOCKING BUFFERS.
6.4 CHALLENGES
6.4.1 ALTERNATIVE TECHNOLOGIES AND APPROACHES FOR INHIBITING BIOLOGICAL BUFFERS.
6.4.2 DISRUPTIONS IN THE SUPPLY CHAIN OF BIOLOGICAL BUFFERS.
7 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE
7.1 OVERVIEW
7.2 GOODS BUFFERS
7.2.1 TRIS BUFFERS
7.2.2 HEPES BUFFERS
7.2.3 MOPS BUFFERS
7.2.4 MES BUFFERS
7.2.5 BIS-TRIS BUFFERS
7.3 OTHER SALT-BASED BUFFERS
7.3.1 PHOSPHATE BUFFERS
7.3.2 ACETATE BUFFERS
7.3.3 CITRATE BUFFERS
7.3.4 AMINO ACID BUFFERS
8 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY FORMULATION
8.1 OVERVIEW
8.2 POWDER
8.3 LIQUID
9 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOPHARMACEUTICALS
9.3 CELL CULTURE & MOLECULAR BIOLOGY
9.4 CLINICAL & DIAGNOSTIC APPLICATIONS
9.5 CHEMICAL & INDUSTRIAL APPLICATIONS
9.6 OTHERS
10 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
10.3 BIOTECHNOLOGY COMPANIES
10.4 RESEARCH & ACADEMIC INSTITUTES
10.5 DIAGNOSTIC LABORATORIES
10.6 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CMOS
11 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY REGION
11.1 NORTH AMERICA
11.1.1 U.S
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 SWOT
14 COMPANY PROFILES
14.1 F. HOFFMANN-LA ROCHE LTD
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT UPDATES
14.2 BIO-RAD LABORATORIES, INC.
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.3 THERMO FISHER SCIENTIFIC, INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT UPDATES
14.4 TAKARA BIO INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 MERCK KGAA, DARMSTADT, GERMANY
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 ADVANCION CORPORATION
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 AVANTOR, INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 BECKMAN COULTER
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 BIOSYNTH
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 FUJIFILM WAKO PURE CHEMICAL CORPORATION
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 GOLDBIO
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 HOPAX
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 HIMEDIA LABORATORIES
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 MP BIOMEDICALS.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 NACALAI TESQUE, INC.
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 PROMEGA CORPORATION
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 QIAGEN
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENT
14.18 REAGECON DIAGNOSTICS LTD
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 SANTA CRUZ BIOTECHNOLOGY INC.
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 SERVA ELECTROPHORESIS GMBH
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 TEVA PHARMACEUTICALS USA, INC.
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)
TABLE 2 NORTH AMERICA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 3 NORTH AMERICA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 4 NORTH AMERICA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 5 NORTH AMERICA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND
TABLE 6 NORTH AMERICA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 7 NORTH AMERICA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 8 NORTH AMERICA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 9 NORTH AMERICA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 10 NORTH AMERICA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 11 NORTH AMERICA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 12 NORTH AMERICA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 13 NORTH AMERICA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 14 NORTH AMERICA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 15 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)
TABLE 16 NORTH AMERICA POWDER IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 17 NORTH AMERICA LIQUID IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 18 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY APPLICATION,2018-2035 (USD THOUSAND)
TABLE 19 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 20 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 21 NORTH AMERICA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 22 NORTH AMERICA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 23 NORTH AMERICA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 24 NORTH AMERICA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 25 NORTH AMERICA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 26 NORTH AMERICA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 27 NORTH AMERICA OTHERS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 28 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)
TABLE 29 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 30 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 31 NORTH AMERICA RESEARCH & ACADEMIC INSTITUTES IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2035 (USD THOUSAND)
TABLE 32 NORTH AMERICA DIAGNOSTIC LABORATORIES IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 33 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 34 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY COUNTRY, 2018-2035 (USD THOUSAND)
TABLE 35 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)
TABLE 36 NORTH AMERICA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 37 NORTH AMERICA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 38 NORTH AMERICA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 39 NORTH AMERICA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 40 NORTH AMERICA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 41 NORTH AMERICA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)
TABLE 42 NORTH AMERICA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 43 NORTH AMERICA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 44 NORTH AMERICA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 45 NORTH AMERICA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 46 NORTH AMERICA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 47 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)
TABLE 48 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)
TABLE 49 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 50 NORTH AMERICA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 51 NORTH AMERICA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 52 NORTH AMERICA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 53 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)
TABLE 54 U.S. BIOLOGICAL BUFFER MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)
TABLE 55 U.S. GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 56 U.S. TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 57 U.S. HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 58 U.S. MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 59 U.S. MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 60 U.S. BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)
TABLE 61 U.S. OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 62 U.S. PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 63 U.S. ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 64 U.S. CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 65 U.S. AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 66 U.S. BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)
TABLE 67 U.S. BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)
TABLE 68 U.S. PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 69 U.S. CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 70 U.S. CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 71 U.S. CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 72 U.S. BIOLOGICAL BUFFER MARKET, BY END USER, 2018-2035 (USD THOUSAND)
TABLE 73 CANADA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)
TABLE 74 CANADA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 75 CANADA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 76 CANADA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 77 CANADA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 78 CANADA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 79 CANADA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)
TABLE 80 CANADA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 81 CANADA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 82 CANADA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 83 CANADA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 84 CANADA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 85 CANADA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)
TABLE 86 CANADA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)
TABLE 87 CANADA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 88 CANADA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 89 CANADA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 90 CANADA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 91 CANADA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)
TABLE 92 MEXICO BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)
TABLE 93 MEXICO GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 94 MEXICO TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 95 MEXICO HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 96 MEXICO MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 97 MEXICO MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 98 MEXICO BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)
TABLE 99 MEXICO OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 100 MEXICO PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 101 MEXICO ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 102 MEXICO CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 103 MEXICO AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 104 MEXICO BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)
TABLE 105 MEXICO BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)
TABLE 106 MEXICO PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 107 MEXICO CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 108 MEXICO CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 109 MEXICO CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)
TABLE 110 MEXICO BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)
List of Figure
FIGURE 1 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE NORTH AMERICA BIOLOGICAL BUFFERS MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2035
FIGURE 12 GOODS BUFFERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA BIOLOGICAL BUFFERS MARKET IN THE FORECAST PERIOD OF 2025 & 2035
FIGURE 13 NORTH AMERICA BIOLOGICAL BUFFERS MARKET EXECUTIVE SUMMARY
FIGURE 14 STRATEGIC DECISIONS
FIGURE 15 DROC
FIGURE 16 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY BUFFER TYPE, 2024
FIGURE 17 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY BUFFER TYPE, 2025-2035 (USD THOUSAND)
FIGURE 18 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY BUFFER TYPE, CAGR (2025-2035)
FIGURE 19 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY BUFFER TYPE, LIFELINE CURVE
FIGURE 20 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY FORMULATION, 2024
FIGURE 21 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY FORMULATION, 2025-2035 (USD THOUSAND)
FIGURE 22 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY FORMULATION, CAGR (2025-2035)
FIGURE 23 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY FORMULATION, LIFELINE CURVE
FIGURE 24 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY APPLICATION, 2024
FIGURE 25 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY APPLICATION, 2025-2035 (USD THOUSAND)
FIGURE 26 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY APPLICATION, CAGR (2025-2035)
FIGURE 27 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY END USER, 2024
FIGURE 29 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY END USER, 2025-2035 (USD THOUSAND)
FIGURE 30 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY END USER, CAGR (2025-2035)
FIGURE 31 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: BY END USER, LIFELINE CURVE
FIGURE 32 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: SNAPSHOT (2024)
FIGURE 33 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: COMPANY SHARE 2024 (%)
